L. T. Shaw3, I. Hariprasad, L. V. Messner, C. A. Bansal, S. A. Schechet, and J. Pérez, “Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature”, BOHR International Journal of Current Research in Optometry and Ophthalmology, vol. 1, no. 1, pp. 74–79, Oct. 2022.